ECAT insider sells 36,173 shares at $16.56–$16.65 — Form 4
Saba Capital Management, L.P. reported insider transactions in BlackRock ESG Capital Allocation Term Trust (ECAT).
Rhea-AI Filing Summary
Saba Capital Management, L.P. reported insider transactions in BlackRock ESG Capital Allocation Term Trust (ECAT). The filing shows two open‑market sales: 5,524 shares sold on 10/02/2025 at $16.56 and 30,649 shares sold on 10/03/2025 at $16.65, totaling 36,173 shares disposed. After these sales, Saba reports an indirect beneficial ownership of 27,746,421 shares. The Form 4 is signed by authorized representatives of Saba on 10/06/2025.
Positive
- Continued large indirect stake of 27,746,421 shares retained after sales
- Transparent Section 16 disclosure with signed Form 4 filed listing transaction details
Negative
- Insider sales totaling 36,173 shares on 10/02/2025–10/03/2025 at $16.56–$16.65
Insights
TL;DR: Reporting shows modest insider sales while retaining a very large indirect stake.
The filing documents two small open‑market sales totaling 36,173 shares at prices between $16.56 and $16.65 on 10/02/2025–10/03/2025
The seller remains an indirect holder with 27,746,421 shares after the transactions, indicating continued significant exposure to ECAT. Watch short‑term trading volume and subsequent filings for changes in pace or size of sales within the next reporting period.
TL;DR: The disclosure is standard Form 4 reporting by a director/10% owner entity.
The form lists Saba Capital Management, L.P. as the reporting person with a checked role of Director and/or 10% Owner, and shows signatures dated 10/06/2025. This meets the structural requirements for Section 16 reporting by insiders.
Monitor subsequent Forms for timing or pattern changes; recurring small sales followed by large retained balances are consistent with portfolio management rather than a change in control or strategy.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 30,649 | $16.65 | $510K |
| Sale | Common Stock | 5,524 | $16.56 | $91K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transactions did Saba Capital report for ECAT (symbol ECAT)?
Who signed the Form 4 for these ECAT transactions?
Were the reported transactions open‑market sales or part of a plan?
Does the filing indicate a change in control or role at ECAT?
AI-generated analysis. How Rhea-AI works. Not financial advice.